Pneumatic burst strength tester for determining medical clothing
Time of Update: 2022-10-13
, Ltd. specializing in the production of pneumatic burst strength tester, engaged in testing instruments for more than ten years, welcome customer inquiries in demand 。 Applicable standards: GB/T7742.
Isn't obesity caused by eating too much
Time of Update: 2021-10-01
In a new study published in The American Journal of Clinical Nutrition on September 14, Beijing time, an authoritative international research team believes that the "energy balance model" has fundamental flaws, and " The carbohydrate-insulin model is of great significance for weight management and obesity treatment .
Novo Nordisk's long-acting treatment for hemophilia A starts phase 3 clinical trials in China
Time of Update: 2021-08-15
On July 28, China’s drug clinical trial registration and information disclosure platform showed that Novo Nordisk has launched the new drug turoctocog alfa pegol (N8-GP) in China for the treatment of
The role of genetic testing in the prevention and treatment of ovarian cancer from the perspective of genetics
Time of Update: 2021-08-05
Based on the outstanding results of the PARP inhibitor olaparib SOLO-1, the FDA quickly approved it as a long-term maintenance treatment for patients with BRCA-mutated ovarian cancer, fallopian tube cancer, and primary peritoneal cancer after first-line chemotherapy after reaching PR or CR after first-line chemotherapy .
Puri Pharmaceuticals Pantoprazole Sodium for Injection Receives Health Canada Approval
Time of Update: 2021-06-22
Pantoprazole Sodium for Injection is a selective long-acting proton pump inhibitor .
It is relatively stable under neutral and weak acidic conditions, and is rapidly activated under strong acidic conditions, thereby having better selectivity for H+ and K+-ATPase .
Two exclusive formulations of 600 million anti-allergic drug companies have been reviewed
Time of Update: 2021-03-27
Brand pattern of the terminal desloratadine in China's public medical institutions in 2019Source: Mi Nei. com, China's public medical institutions terminal competition patternThe desloratadine products currently on the market in China include desloratadine tablets, desloratadine dispersible tablets, desloratadine dry suspension, desloratadine capsules, desloratadine syrup and Deloratadine oral solution.
FDA approves Alexion's long-acting C5 tonic inhibitor Ultromiris (ravulizumab-cwvz) extended indications
Time of Update: 2020-06-07
recently, Alexion Pharmaceuticals (http:// announced that the U.S FDA (http:// approved the company's long-acting C5 tonic inhibitor Ultromiris (ravulizumab-cwvz) extended indications for the
U.S. develops AIDS prevention drug 100% effective in monkeys
Time of Update: 2020-06-03
Business, March 6 (Upi) -- Scientists have developed a new type of injectable drug that has been shown to be effective in preventing HIV in monkeys, according to a study published in the American j